Detalhe da pesquisa
1.
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation.
Cancer Immunol Immunother
; 71(4): 865-874, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462870
2.
The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer.
Oncologist
; 25(8): 661-668, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32202020
3.
The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients' quality of life.
Support Care Cancer
; 27(12): 4697-4704, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30949832
4.
Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis.
Tumori
; 109(2): 233-243, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35361017
5.
Therapeutic sequencing in advanced renal cell carcinoma: How to choose considering clinical and biological factors.
Crit Rev Oncol Hematol
; 181: 103881, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36427772
6.
Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study.
Eur J Cancer
; 189: 112920, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37277262
7.
Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review.
Semin Oncol
; 49(6): 476-481, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36759234
8.
Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine?
Cells
; 11(10)2022 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35626651
9.
New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine?
Crit Rev Oncol Hematol
; 174: 103682, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35421529
10.
New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond.
Cells
; 11(3)2022 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35159167
11.
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma.
Crit Rev Oncol Hematol
; 172: 103639, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35192932
12.
Performing oncological procedures during COVID-19 outbreak: a picture from an Italian cancer center.
Explor Target Antitumor Ther
; 2(5): 481-489, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-36045703
13.
Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review.
Eur J Cancer
; 149: 49-60, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33823362
14.
Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC.
Endocr Relat Cancer
; 28(7): R207-R216, 2021 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33949971
15.
Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave.
Crit Rev Oncol Hematol
; 157: 103189, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33341505
16.
SARS-CoV-2 Infection in Cancer Patients: A Picture of an Italian Onco-Covid Unit.
Front Oncol
; 10: 1722, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32974210
17.
Impact of adoption of patient-reported outcomes in clinical practice on the accuracy of symptom reporting in medical records of cancer patients.
Recenti Prog Med
; 111(12): 740-748, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33362171
18.
Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study.
Lung Cancer
; 150: 123-131, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33130353
19.
Second-line treatment options in hepatocellular carcinoma.
Drugs Context
; 8: 212577, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31024634
20.
Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation-based therapy.
Cancer Commun (Lond)
; 42(8): 683-688, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35866986